Regeneron Pharmaceuticals, Inc. company logo
Regeneron Pharmaceuticals, Inc. logo

REGN Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$2.49B$241.80M-8.86%

Summary

Current Value
As of today, REGN annual cash & cash equivalents is $2.49B, down -8.86% on
Historical Performance
REGN annual cash & cash equivalents is down -13.77% over the past 3 years, and up +53.80% over the past 5 years
All-Time High Comparison
REGN annual cash & cash equivalents is currently -19.89% below its historical high of $3.11B set on
3-Year Low Comparison
REGN annual cash & cash equivalents is at its 3-year low
Sector Comparison
REGN annual cash & cash equivalents is higher than 96.26% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

REGN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$2.49B-8.9%-13.8%+53.8%+1101.6%
Quarterly Cash & Cash Equivalents$8.45B-13.7%+20.4%+179.3%+1664.0%
Price$796.55+8.6%+17.1%+59.7%+2235.9%
Annual Current Assets$18.66B-4.2%+33.1%+142.7%+4285.6%
Annual Total Liabilities$8.50B+18.7%+27.5%+128.7%+2367.4%
Annual Working Capital$14.72B-8.3%+46.0%+163.2%+4333.6%
Annual Net Income$4.41B+11.6%-45.4%+108.5%+6605.4%

Cash and Cash Equivalents Highs

REGN Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$3.11BN/A-19.9%
5Y$3.11B-19.9%
All$3.11B-19.9%

Cash and Cash Equivalents Lows

REGN Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$2.49Bat low
5Y$2.19BN/A+13.4%
All$12.50M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$2.49B-8.9%
$2.73B-12.1%
$3.11B+7.6%
$2.89B+31.5%
$2.19B+35.6%
$1.62B+10.2%
YearValueChange
$1.47B+80.6%
$812.70M+51.8%
$535.20M-33.9%
$809.10M+24.7%
$648.72M-

FAQ

  • What is the current annual cash & cash equivalents of REGN?

    As of today, REGN annual cash & cash equivalents is $2.49B

  • What is 1-year change in REGN annual cash & cash equivalents?

    REGN annual cash & cash equivalents is down -8.86% year-over-year

  • What is 3-year change in REGN annual cash & cash equivalents?

    REGN annual cash & cash equivalents is down -13.77% over the past 3 years

  • How far is REGN annual cash & cash equivalents from its all-time high?

    REGN annual cash & cash equivalents is currently -19.89% below its historical high of $3.11B set on December 31, 2022

  • How does REGN annual cash & cash equivalents rank versus sector peers?

    REGN annual cash & cash equivalents is higher than 96.26% of companies in Healthcare sector

  • When is REGN next annual earnings release?

    The next annual earnings release for REGN is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. REGN Official Website www.regeneron.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm
  4. REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
  5. REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn